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Both ADAM17, the secretase responsible for the shedding of ectodomains of numerous mem-
brane proteins including TNF and its receptors, as well as nitric oxide synthesized by inducible 
nitric oxide synthase play regulatory roles in inflammation and tumor progression. We analyzed 
the effect of endogenous and exogenous nitric oxide on the expression and activity of ADAM17 
in murine endothelial cells and a monocyte/macrophage cell line. We found that endogenous ni-
tric oxide influenced neither ADAM17 mRNA level nor the shedding of two ADAM17 substrates, 
TNF and TNFR1. Exogenous NO significantly diminished the release of TNF and TNFR1 without 
affecting the ADAM17 transcript level. Our data seem contrary to a previous report that showed 
the activation of ADAM17 by nitric oxide (Zhang et al., 2000, J Biol Chem 275: 15839–15844). We 
discuss potential mechanisms of NO-mediated inhibition of ectodomain shedding and possible 
reasons of discrepancy between our results and the previous report. 
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INTRODUCTION
ADAM17, also known as TACE (tumor necro-
sis factor-α converting enzyme), has been identified 
as the main secretase responsible for releasing the 
soluble form of tumor necrosis factor (TNF) from 
the plasma membrane. It belongs to the ADAM (a 
disintegrin and metalloprotease domain) family of 
transmembrane, multidomain zinc metalloprotein-
ases (Black et al., 1997; Moss et al., 1997). ADAM17 
plays a vital role in development through the 
processing of numerous growth factors and growth 
factor receptors (Arribas & Ruiz-Paz, 2005) and in 
immunoregulation through the shedding of TNF, as 
well as ectodomains of both TNF receptors (Peschon 
et al., 1998; Reddy et al., 2000), interleukin (IL)-1-RII 
(Reddy et al., 2000), IL-6-Rα (Althoff et al., 2000), 
L-selectin (Peschon et al., 1998), vascular cell adhe-
sion molecule-1 (VCAM-1) (Garton et al., 2001; 2003), 
fractalkine (Garton et al., 2001) and others (Arribas 
& Ruiz-Paz, 2005). Thus, the effect of ADAM17 on 
the immune system seems to be complex. Its activity 
towards TNF and IL-6Rα could potentiate the proin-
flammatory effects of the cytokines, whereas shed-
ding of TNF receptors, IL-1-RII, and cell adhesion 
molecules should limit the inflammatory response 
(Mężyk et al., 2003). The proinflammatory activity of 
ADAM17 was well documented by in vivo studies of 
Horiuchi et al. (2007) who showed that conditional 
knockout mice lacking ADAM17 in myeloid cells are 
resistant to endotoxin shock, presumably due to lim-
ited shedding of TNF. The activity of ADAM17 is 
strongly enhanced by phorbol esters, and although 
the mechanism of this process has been extensive-
ly investigated, it is still poorly understood (Arri-
bas & Ruiz-Paz, 2005). The expression of ADAM17 
was shown to be increased in vitro in different cell 
types exposed to proinflammatory cytokines (Xu et 
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al., 2002; Bzowska et al., 2004; Gomez et al., 2005) as 
well as in vivo in different cells and tissues under in-
flammatory conditions (Colon et al., 2001; Bohgaki et 
al., 2005; Kermarrec et al., 2005). A highly increased 
expression of ADAM17 is also characteristic for nu-
merous types of tumors (Borrell-Pages et al., 2003; 
Ding et al., 2004; Blanchot-Jossic et al., 2005) and an 
involvement of this secretase in tumor progression 
has been implied by certain studies (Franovic et al., 
2006).
Nitric oxide is produced in large quantities 
by inducible nitric oxide synthase expressed dur-
ing inflammation in various cell types, including 
macrophages and endothelial cells. This smallest 
natural signaling molecule has bactericidal activ-
ity (Murray & Nathan, 1999; Eriksson et al., 2003) 
but it is also involved in the regulation of immune 
system functioning; for instance, it inhibits T-cell 
proliferation and differentiation, B-cell prolifera-
tion and antibody production, as well as modu-
lates the expression of some cytokines and inhibits 
the endothelial expression of cell adhesion mol-
ecules, thus limiting the adherence of leukocytes 
to the endothelium and their migration to the sites 
of injury (Bogdan, 2001). NO produced in excess 
can be harmful to the host. It is partly responsible 
for LPS-induced hypotension and multiple organ 
dysfunction (MacMicking et al., 1995). Nitric oxide 
is also produced in tumors by tumor-associated 
macrophages or due to the expression of iNOS in 
tumor cells. Depending on tumor cell type and 
tumor microenvironment it may lead to an inhibi-
tion of tumor growth or, on the contrary, to tumor 
progression, which partially results from nitric ox-
ide-stimulated tumor neovascularization (Bogdan, 
2001). 
Nitric oxide derived from an NO donor has 
been shown to activate ADAM17 (Zhang et al., 2000). 
However, since both molecules play important roles 
in inflammation and tumor growth, and nitric ox-
ide has diverse effects on various cellular processes, 
we decided to investigate the effect of endogenous 
and exogenous nitric oxide on the expression and 
activity of ADAM17 in endothelial cells and cells of 
monocyte/macrophage origin. 
MATERIALS AND METHODS
Murine cell lines. MBE-SV, murine brain mi-
crovascular endothelial cells (a gift from Dr. R. Au-
erbach, Madison, WI, USA) immortalized with SV40 
large T antigen; P388/D1, murine monocyte/macro-
phage cell line (ATCC#CCL-46); ADAM17–/–TNF+, 
Ras-Myc-immortalized murine fibroblasts isolated 
from ADAM17∆Zn/∆Zn mice, a gift from Dr. R. A. 
Black (Amgen Inc., Seattle, WA, USA) stably trans-
fected with human proTNF cDNA (Mężyk-Kopeć et 
al., 2005).
Chemicals. Antibodies: murine monoclonal 
anti-human TNF (Biocentrum Ltd., Kraków, Poland), 
rabbit polyclonal anti-human TNF (Sigma), rabbit 
polyclonal anti-murine TNFR1 (Santa Cruz), horse-
radish peroxidase (HRP)-conjugated anti-murine 
IgG (Sigma), FITC-conjugated anti-murine IgG (Sig-
ma); NO donors: S-nitroso-N-acetylpenicillamine 
(SNAP) (Sigma) and (Z)-1-[N-(2-aminopropyl)-N-
(2-ammoniopropyl)amino]-diazen-1-ium-1,2-diolate 
(PAPA-NO) (Alexis); l-NG-monomethyl arginine (l-
NMMA) and d-NG-monomethyl arginine d-NMMA 
(Alexis). Cytokines: recombinant human (rh) TNF 
(Suntory Pharmaceuticals), rhIL-1β (Sigma), re-
combinant murine (rm) IFNγ (Genzyme). Plasmid 
pcDNA3.1 coding for muADAM17 (pcDNA3.1/mu-
ADAM17) was a gift from Dr. R. A. Black (Amgen 
Inc.).
Cell cultures. All cell lines were cultured in 
DMEM/Glutamax-1 supplemented with 10% FBS at 
37°C in 5% CO2. Culture medium for ADAM17
–/–
TNF+ cells was enriched in geneticin (1.5 mg/ml) and 
in zeocin (500 µg/ml) every few passages. 
Analysis of the influence of endogenous 
nitric oxide on shedding of ADAM17 substrates. 
The cells were incubated in 96-well plates for 24 h 
in DMEM enriched in 2% FCS containing cytokines 
in order to stimulate iNOS expression. MBE-SV cells 
were stimulated with rhTNF (10 ng/ml), rhIL-1β (10 
ng/ml) and rmIFNγ (200 U/ml) and P388/D1 cells 
with rhIL-1β and rmIFNγ and additionally LPS 
(100 ng/ml). To some experimental groups an iNOS 
inhibitor, l-NG-monomethyl arginine (l-NMMA, 
2 mM) or its non-active stereoisomer, d-NMMA 
(2 mM), was added. After 24 h the medium was re-
placed with fresh DMEM (2% FCS), ADAM17 activ-
ity was stimulated by the addition of PMA (250 nM) 
and the cells were incubated for additional 45 min. 
The concentrations of TNF in the media of P388/D1 
cells were measured by ELISA using BenderMedSys-
tem (Vien, Austria). For the measurement of TNFR1 
shedding, the MBE-SV cells were biotinylated using 
a standard protocol (Ausubel et al., 1995) prior to 
PMA activation. The levels of biotinylated TNFR1 in 
the media of MBE-SV cells were estimated by ELISA 
using polyclonal anti-mouse TNFR1 as a capture an-
tibody (5 µg/ml) and HRP-conjugated streptavidin 
(1 : 10 000) as a detection molecule.
Analysis of the influence of exogenous nitric 
oxide on shedding of ADAM17 substrates. MBE-
SV cells and ADAM17–/–TNF+ cells were incubated 
for 6 or 24 h in the presence of different concentra-
tions of SNAP or for 3 h in the presence of differ-
ent concentrations of PAPA-NO. P388/D1 cells were 
incubated with LPS (100 ng/ml) in order to stimulate 
TNF synthesis. SNAP was added for the whole in-
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cubation period or for the last 6 h. PAPA-NO was 
added for the last 3 h of the incubation period. After 
incubation the medium was collected and the con-
centrations of nitrite were measured as described 
below. The cells were incubated in fresh medium 
for an additional 45 min in the presence or absence 
of PMA (in the case of MBE-SV and P388/D1 cells) 
or ionomycin (in the case of ADAM17–/–TNF+ cells). 
The level of murine TNF released from P388/D1 
cells and TNFR1 released from MBE-SV cells was 
measured as described previously. Human TNF re-
leased from ADAM17–/–TNF+ cells was measured by 
ELISA using polyclonal anti-hTNF as a capture an-
tibody and monoclonal murine anti-hTNF followed 
by HRP-conjugated anti-murine IgG as detection an-
tibodies. 
Northern blot analysis. Total RNA was ex-
tracted from MBE-SV and P388/D1 cells after in-
cubation with the cytokines or the NO donors by 
the method of Chomczynski and Sacchi (1987). 
Equal amounts of RNA (10 µg) were fractionated 
by electrophoresis under denaturing conditions in 
a 1% agarose-formaldehyde gel and transferred 
to Hybond-NX membrane (Amersham Biocienc-
es, Little Chalfont, UK). Probes for muADAM17 
cDNA were obtained by digestion of pcDNA3.1/
muADAM17 with NotI and KpnI. The membranes 
were hybridized overnight at 65oC with the rel-
evant probe labeled with [α-32P]dCTP by random 
priming using High Prime DNA Labeling system 
(Roche, Basel, Switzerland). After extensive wash-
ing the blots were exposed to an X-ray film or to 
a phosphoimager screen and the autoradiograms 
were analyzed using Personal Molecular Imager 
FX (BioRad, Hercules, CA, USA) and Quantity 
One software (BioRad). Autoradiographic signals 
were normalized to the intensity of ethidium bro-
mide-stained 28S rRNA after subtraction of back-
ground. 
Nitrite assay. Nitrite concentration in the 
medium was determined by a microplate assay. 
Briefly, 100 µl aliquots of culture media were in-
cubated with equal volumes of Griess reagent (1% 
sulfanilic acid/0.1% N-(1-naphtyl)ethylenediamine 
dihydrochloride (Sigma) in 2.5% H3PO4) at room 
temperature for 10 min. The absorbance at 545 nm 
was measured with a microplate reader. Nitrite con-
centration was determined by using dilutions of so-
dium nitrite in medium as a standard. 
Cytotoxicity assay. The potential cytotoxic ef-
fects of endogenous NO and of NO donors was de-
termined by the MTT test (Celis, 1998). Following the 
incubation of the cells with the cytokines or the NO 
donors, the medium was replaced with fresh medium 
containing MTT (0.5 mg/ml) and the cells were incu-
bated for an additional 6 h. The absorbance of solubi-
lized formazan was measured at 562 nm.
Zymography. Proteins in media collected af-
ter the incubation of the cells with the cytokines or 
the NO donors were resolved by SDS/PAGE under 
non-reducing conditions in a gel containing 1% gela-
tin. Next, the gels were washed extensively for 2 h 
in 2.5% solution of Triton X-100 in deionized wa-
ter, incubated overnight at 37°C in reaction buffer 
(10 mM CaCl2, 0.15 M NaCl, 50 mM Tris, pH 7.0) 
and stained with Coomassie brilliant blue. The zy-
mograms were analysed using Fluor-S Multi Imager 
and Quantity One software.
Flow cytometric analysis. The ADAM17–/–
TNF+ cells were stained according to standard pro-
cedures with murine anti-hTNF and FITC-conjugat-
ed anti-murine IgG and the staining of the cells was 
analyzed vs. an isotype control on a FACScan flow 
cytometer (Becton Dickinson, USA) using Cell-Quest 
software.
Protein biosynthesis. [3H]leucine (Amer-
sham) was added to the culture medium of the cells 
during the incubation with the NO donors for the 
whole incubation periods (in the case of the short 
incubations) or for the last 6 h of 24 h-incubation. 
The incorporation of [3H]leucine into TCA-precipi-
tated proteins present in the culture medium as well 
as in cell lysates was measured using a beta-scintil-
lation counter (Wallac 1414).
Statistical analysis. All data comes from at 
least 3 independent repeats of experiments per-
formed at least in triplicates, unless indicated other-
wise. Statistical analysis was performed using Stu-
dent’s t-test with P < 0.05 considered significant. 
RESULTS
Lack of effect of endogenous or exogenous nitric 
oxide on ADAM17 mRNA level
We have previously shown that the expres-
sion of ADAM17, the major TNF sheddase, is up-
regulated by pro-inflammatory cytokines in murine 
endothelial cells (MBE-SV) (Bzowska et al., 2004). 
This stimulatory effect was not observed in the 
P388/D1 monocyte/macrophage cell line in which 
the basal level of ADAM17 mRNA is very high. 
Since the cytokine-mediated activation of cells, in-
cluding MBE and P388/D1, results in the synthe-
sis of large amounts of nitric oxide (NO) due to 
iNOS induction we decided to analyze its effect 
on ADAM17 expression. The highest expression of 
iNOS in MBE-SV can be achieved by stimulating 
the cells with three cytokines (TNF+IL-1β+IFNγ), 
whereas in P388/D1 it requires stimulation with IL-
1β, IFNγ and LPS. The levels of NO, endogenously 
produced or released from NO donors, can be esti-
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mated by measuring the accumulation of nitrite, a 
product of NO oxidation. 
To discriminate between the effect of the 
cytokines and that of nitric oxide produced in re-
sponse to the cytokines, the cells were incubated in 
the presence or absence of l-NMMA, a competitive 
inhibitor of iNOS that almost completely abolished 
NO synthesis (Fig. 1A). Although endogenous nitric 
oxide may influence the expression of some genes 
in MBE cells (Bereta & Bereta, 1995), it did not af-
fect ADAM17 mRNA level in these cells (Fig. 1A). 
The levels of ADAM17 mRNA were comparable 
in MBE-SV stimulated with the cytokines in the 
absence of l-NMMA (high level of NO) and in the 
presence of l-NMMA (low level of NO). Similarly, 
we did not observe any changes in ADAM17 mRNA 
expression in P388/D1 cells stimulated with the cy-
tokines and LPS in the presence or absence of the 
iNOS inhibitor (not shown). Also exogenous nitric 
oxide released from SNAP, an NO donor, had no ef-
fect on ADAM17 mRNA level in MBE-SV (Fig. 1A) 
or P388/D1 cells (Fig. 1B). 
Exogenous but not endogenous nitric oxide inhibits 
the release of ADAM17 substrates
Simultaneously with the analysis of ADAM17 
expression we evaluated the activity of the enzyme 
and, surprisingly, we obtained results contradictory 
to those of Zhang et al. (2000). In our cell models ex-
ogenous nitric oxide did not enhance ADAM17 activ-
ity, but rather inhibited the release of ADAM17 sub-
strates to the culture medium. We measured the re-
lease of TNF from P388/D1 cells and TNF receptor 1 
(TNFR1) from MBE cells during a 45-min incubation 
of the cells with or without PMA (an ADAM17 acti-
vator) that followed 6- or 24-h incubation of the cells 
with SNAP at different concentrations. The P388/D1 
cells released only negligible amounts of TNF with-
out PMA stimulation and thus the effect of SNAP 
on the basal TNF release was not analyzed. How-
ever, the amount of TNF released from the cells ac-
tivated with PMA was strongly decreased by SNAP. 
The strongest inhibition, close to 70%, was observed 
for the cells incubated for 24 h with 500 µM SNAP, 
although the effect of 50 µM SNAP was already sig-
nificant (Fig. 2). Less pronounced effects were ob-
served after 6-h incubation of the cells with SNAP 
(47% inhibition at 500 µM SNAP), although the de-
composition of the NO donor was already complete 
as the concentrations of nitrite in the media were the 
same as in the case of the 24-h incubation (Fig. 2). 
MTT assay performed after 6- and 24-h incubation 
of P388/D1 cells with the NO donor demonstrated 
that it did not influence the cell viability or metabo-
lism (not shown). 
SNAP affected also basal- and PMA-activated 
release of TNFR1 from MBE-SV cells (Fig. 3A). Ni-
tric oxide seemed to have a stronger impact on the 
PMA-activated process. Similarly to the inhibition of 
TNF shedding from P388/D1 cells, also the inhibition 
of TNFR1 shedding from MBE-SV cells was more 
pronounced after prolonged incubation of the cells 
with SNAP (55% inhibition after 24 h vs. 41% after 
6 h at 500 µM SNAP). Unlike the P388/D1 cells, 
MBE-SV cells exposed to SNAP at high concentra-
tions (500 and 250 µM) for 24 h showed a moder-
Figure 1. Northern blotting analysis of the ef-
fect of nitric oxide on ADAM17 mRNA level 
in MBE-SV and P388/D1 cells. 
A. MBE-SV cells were incubated for 24 h with 
medium alone (control), with l-NMMA, with 
the cytokines TNF, IL-1β and IFNγ in the pres-
ence or absence of l-NMMA or its stereoisomer 
d-NMMA, or with SNAP. B. P388/D1 cells were 
incubated in medium alone or in the presence 
of SNAP. After incubation, nitrite concentrations 
were measured in the culture media (lower 
panel). Numbers indicate the strength of densi-
tometric signals relative to the signal of control 
sample. Data are representative of 3 experi-
ments.
Figure 2. Influence of SNAP on TNF release from P388/
D1 cells. 
P388/D1 cells were incubated for 6 or 24 h with various 
concentrations of SNAP. At the end of the incubation, 
nitrite concentration was measured in the medium. Af-
ter medium replacement, PMA was added for additional 
45 min and the level of TNF released to the medium was 
measured by ELISA. *P < 0.05.
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ately decreased ability to reduce tetrazolium salt in 
the MTT assay (22 and 14%, respectively), which 
may indicate that high levels of NO influenced cell 
viability or oxidative metabolism to some extent 
(Fig. 3B). 
Although the NO donor strongly inhibited 
the release of ADAM17 substrates, no such effect 
was observed for endogenously produced nitric ox-
ide. The levels of TNF in the medium of P388/D1 
cells did not change upon stimulation of the cells 
with the cytokines under conditions that allowed 
nitric oxide synthesis (in the absence of l-NMMA) 
nor in the presence of l-NMMA, which prevented 
NO synthesis (Fig. 4A). The treatment of MBE-SV 
cells with the cytokines resulted in a significant in-
crease in sTNFR1 release to the culture medium due 
to the stimulation of ADAM17 expression (Bzowska 
et al., 2004). However, the level of sTNFR1 release 
did not depend much on the synthesis of NO, since 
the presence of the iNOS inhibitor did not influence 
the level of sTNFR1 in the medium of MBE-SV cells 
(Fig. 4B). Even lowering of the volume of the cul-
ture medium, which resulted in an increase of nitrite 
concentration to a level similar to that obtained us-
ing SNAP led only to a slight inhibition of TNFR1 
release to the medium (Fig. 4C).
The effect of exogenous nitric oxide is not limited 
to inhibition of ADAM17 activity
We then investigated whether the shedding 
inhibition by exogenous nitric oxide was limited 
to inhibiting ADAM17 activity. We considered the 
possibility that nitric oxide may affect the activ-
ity of a whole group of zinc metalloproteases with 
similar active centers, since reactive nitrogen spe-
cies may influence zinc-containing proteins. There-
fore, we analyzed the effect of SNAP on the release 
of TNF from ADAM17–/–TNF+ fibroblasts as well 
as on the activity of matrix metalloproteases se-
Figure 3. Influence of SNAP on TNFR1 
release from MBE-SV cells. 
MBE-SV cells were incubated for 6 or 24 h 
with various concentrations of SNAP. At 
the end of the incubation, nitrite concentra-
tion was measured in the medium. After 
medium replacement, the cells were incu-
bated in the presence or absence of PMA 
for additional 45 min. A. Levels of TNFR1 
released to the medium measured by ELI-
SA. B. Cell viability/mitochondrial activity 
measured by MTT assay. *P < 0.05.
Figure 4. Influence of endogenous nitric oxide on TNF and TNFR1 release from P388/D1 and MBE-SV cells. 
A. P388/D1 cells were incubated for 24 h in medium alone (control), with IL-1β + IFNγ + LPS, or with IL-1β + IFNγ + 
LPS in the presence of l-NMMA. After medium replacement, the incubation was continued for additional 45 min in the 
presence of PMA and the concentration of TNF released to the medium was measured by ELISA. B and C. Cells were 
incubated for 24 h with medium alone (control) or with the cytokines TNF, IL-1β, IFNγ in the presence or absence of 
l-NMMA. After medium replacement, the incubation was continued for additional 45 min in the presence or absence of 
PMA and the level of TNFR1 in the medium was measured using ELISA. B. the cells were incubated in a standard vol-
ume of the medium (100 µl). C. The cells were incubated in a decreased volume of the medium (50 µl). After incubation 
of the cells with the cytokines (or the cytokines and LPS) nitrite concentration was measured in culture medium. 
330            2009M. Bzowska and others
creted by MBE-SV cells. We have documented that 
ADAM10 is mostly responsible for the shedding of 
TNF from ADAM17–/–TNF+ cells (Mężyk-Kopeć et 
al., 2009). The moderate inhibition of TNF release 
from ADAM17–/–TNF+, both unstimulated and ac-
tivated with ionomycin (an activator of ADAM10) 
after exposure of the cells to SNAP indicated that 
also ADAM10-mediated shedding was impaired 
by exogenous nitric oxide (Fig. 5A), although to a 
much lesser extent than PMA-activated shedding 
from P388/D1 and MBE-SV cells (see Figs. 2 and 3). 
SNAP did not affect the viability of ADAM17–/–TNF+ 
cells (not shown). Similarly, the activities of all col-
lagen-specific MMPs were diminished in the me-
dium of MBE-SV cells treated with SNAP (Fig. 5B). 
However, unexpectedly, when SNAP was added 
for 6 h not directly to the cell culture but to the 
medium collected after cell incubation, no inhibito-
ry effect of SNAP was observed (data not shown). 
This finding indicated that nitric oxide did not in-
fluence the enzymatic activity of MMPs, but rather 
their synthesis, intracellular transport or secretion. 
Based on this observation it seems plausible that 
also the effect of exogenous nitric oxide on proteins 
of the ADAM family does not consist in inhibiting 
their enzymatic activity. 
PAPA-NO, another NO donor, strongly inhibits the 
release of ADAM17 substrates
The discrepancy between our results and 
those of Zhang et al. (2000) might result from the 
different NO donors used. Therefore, we repeated 
some of our experiments using the same NO donor 
(PAPA-NO) with the same concentrations and the 
same incubation period (3 h) as applied by Zhang et 
al. (2000). The kinetics of NO release from PAPA-NO 
is very fast; the plateau of nitrite concentration is 
obtained already in 5 min after solubilization of the 
compound; moreover, the concentrations of PAPA-
NO that were used resulted in the accumulation of 
enormous, non-physiological concentrations of ni-
trite (> 600 µM for 1 mM PAPA-NO). Under such 
conditions the inhibitory effect of PAPA-NO on the 
shedding of ADAM17 substrates was even stronger 
than that of SNAP (Fig. 6). 
NO donors influence protein synthesis
Our finding that exogenous nitric oxide did 
not influence the enzymatic activity of MMPs led 
us to the question about the mechanisms, other 
than impaired enzyme effectiveness, that could be 
Figure 5. Influence of exogenous nitric oxide on the activity of metalloproteases other than ADAM17.
A. Levels of TNF released to the medium from ADAM17–/–TNF+ cells incubated in the presence or absence of ionomycin 
after their 6-h exposure to SNAP, measured by ELISA. B. Activity of MMPs released to the medium by MBE-SV cells-
during their 6-h exposure to various concentrations of SNAP, estimated by zymography. Numbers indicate the strength 
of densitometric signals relative to the signal of control sample. Data are representative of 3 experiments. *P < 0.05.
Figure 6. Effect of PAPA-NO on the release of TNF from 
P388/D1 and ADAM17–/–TNF+ cells and TNFR1 from 
MBE-SV cells. 
Cells were incubated for 3 h with different concentrations 
of PAPA-NO and after medium replacement, the incuba-
tion was continued for additional 45 min in the absence 
or presence of PMA (P388/D1 and MBE-SV) or ionomycin 
(ADAM17–/–TNF+). Concentrations of TNF or TNFR1 in the 
media were measured by ELISA. Table shows the concen-
trations of nitrite generated from different concentrations 
of PAPA-NO. Data concerning the influence of PAPA-NO 
on ionomycin-treated ADAM17–/–TNF+ cells come from a 
single experiment performed in triplicate. *P < 0.05.
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responsible for the decreased release of ADAM17 
substrates. We hypothesized that it could result 
from the inhibition of more general processes in the 
cells, such as protein synthesis or intracellular traf-
ficking. We therefore analyzed the incorporation of 
[3H]leucine into cellular and secreted proteins in cul-
tures of MBE-SV, P388/D1 and ADAM17–/–TNF+ cells 
treated with SNAP for 6 or 24 h or PAPA-NO for 
3 h. We found that both NO donors inhibited pro-
tein synthesis to some extent in all cell lines studied 
and that the effect of PAPA-NO (1 mM) was strong-
er than that of SNAP (500 µM) (Fig. 7). PAPA-NO 
at 0.1 mM influenced protein synthesis almost as 
efficiently as at 1 mM. The final accumulation of 
nitrite in the SNAP solution (500 µM) was around 
70 µM and in PAPA-NO (100 µM) around 100 µM. 
The stronger effect of PAPA-NO may have result-
ed from the different kinetics of NO release from 
both compounds. The immediate decomposition of 
PAPA-NO may lead to a peak of nitric oxide con-
centration much higher than in the case of SNAP. 
The inhibition of [3H]leucine incorporation into cel-
lular proteins was more pronounced than into the 
pool of proteins released to the medium, which sug-
gested that nitric oxide did not affect overall protein 
secretion. Comparing different cell lines, we did not 
observe a correlation between the level of shedding 
inhibition and the level of the inhibition of protein 
synthesis. The highest inhibition of shedding was 
observed for P388/D1 cells, in which the protein 
synthesis was the least affected. Moreover, the inhi-
bition of TNF release from P388/D1 cells was more 
pronounced 24 h after adding SNAP to the medi-
um, whereas the inhibition of protein synthesis was 
stronger after 6 h, probably due to a temporary ef-
fect of nitric oxide on this process.
NO donors do not influence the surface levels of 
TNF on ADAM17–/–TNF+ cells
The observed decrease in the amount of TNF 
and TNFR1 released to the medium could also be 
a result of a diminished level of these proteins in 
the membrane due to impaired protein synthesis, 
which could have caused a decreased availability 
of substrates for ADAM17 or ADAM10. We were 
unable to detect TNF on the surface of P388/D1 or 
TNFR1 on the surface of MBE-SV by flow analysis; 
we therefore analyzed the effect of exogenous ni-
tric oxide on TNF level on ADAM17–/–TNF+ which 
express high levels of TNF on the cell surface. We 
did not observe significant changes in the number of 
TNF-positive cells or in the mean fluorescence inten-
sity after the exposure of the cells to SNAP for 6 h 
(Fig. 8).
DISCUSSION
Cytokines stimulate ADAM17 expression in 
murine endothelial cells (Bzowska et al., 2004). In 
these studies we found that nitric oxide generated in 
MBE-SV cells in response to inflammatory mediators 
did not modulate cytokine-upregulated ADAM17 
mRNA level. Similarly, endogenous nitric oxide had 
no influence on the already high level of ADAM17 
mRNA in P388/D1 cells. Endogenous nitric oxide had 
also no effect on the levels of ADAM17 substrates, 
TNF and TNFR1, released to the medium after 24 h 
stimulation of P388/D1 or MBE-SV cells. Only at the 
highest possible concentration of endogenous NO re-
sulting in the accumulation of almost 90 µΜ nitrite in 
the medium of MBE-SV cells was a slight decrease of 
TNFR1 level observed in the medium. 
Figure 7. Effect of NO donors on total protein synthesis. 
Incorporation of [3H]leucine into proteins was measured in lysates and culture media of cells exposed to NO donors. 
*P < 0.05.
Figure 8. Flow cytometric analysis of TNF surface level 
on ADAM17–/–TNF+ cells.
Cells were exposed for 6 h to SNAP (500 µM). Data are 
representative of 3 experiments performed in duplicates.
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The exposure of cells to the NO donor SNAP 
did not influence ADAM17 expression but signifi-
cantly reduced the levels of ADAM17 substrates re-
leased to the culture medium. Our results are seem-
ingly contradictory to those of Zhang et al. (2000) 
who showed that another NO donor, PAPA-NO, ac-
tivated ADAM17, which resulted in the increased ra-
tio of soluble versus cell-bound ADAM17 substrates. 
One possibility was that the discrepancy between the 
Zhang’s results and ours consisted in the type of the 
NO donor used. We applied moderate concentrations 
of SNAP that slowly releases NO (a maximum level 
of nitrite is observed 6 h after adding the compound 
to the medium) whereas Zhang and coworkers used 
high concentrations of PAPA-NO that immediately 
releases all nitric oxide (Fig. 9). However, we rejected 
this hypothesis since in our hands PAPA-NO also in-
hibited shedding of ADAM17 substrates. The possi-
bility that the discrepancy is due to the use of distinct 
cell lines is not very likely (although not dismissible) 
since both studies included cell lines of macrophage 
origin and, moreover, the mechanism of NO-mediat-
ed ADAM17 activation proposed by Zhang and cow-
orkers is so general that it should apply to all cells. 
The major difference between our and 
Zhang’s experiments lay in their scheme and time-
course. Zhang and coworkers measured the release 
of ADAM17 substrates during 2- or 3-h incubation 
of the cells with the NO donor, thus they analyzed 
the immediate effects of exogenously generated NO, 
whereas we, in order to examine the effect of NO on 
PMA-induced shedding, had to replace the medium 
with a fresh one to avoid the high background of 
ADAM17 substrates present in the medium before 
the addition of PMA. Thus we analyzed late effects 
of nitric oxide on the cells. The results of Zhang and 
coworkers also showed that the ratio of soluble to 
membrane TNF after 2-h incubation was signifi-
cantly higher than that observed after 3-h incubation 
of Mono Mac 6 cells in the presence of LPS, PMA 
and PAPA-NO (Zhang et al., 2000), which may sug-
gest that the stimulatory effect of nitric oxide on 
ADAM17 is transitory. 
What could be the reason for the diminished 
levels of TNF and TNFR1 released from the surface 
of the cells after their exposure to the NO donors? 
We can exclude the hypothesis that the mechanism 
involves an NO signaling pathway, the activation 
of a soluble guanylate cyclase and cGMP-dependent 
protein kinase, since in that case the effects would 
be observed already at much lower (nanomolar) NO 
concentrations. Nitric oxide and NO-derived reactive 
nitrogen species (RNS), present at high concentra-
tions, may react with proteins leading to S-nitrosyla-
tion of thiol groups, nitration of tyrosine residues, 
inactivation of heme, or disruption of metal-sulfide 
clusters. This may affect the activity of numerous 
proteins (for instance kinases, transcription factors, 
enzymes of electron transport chain, G-proteins) in-
volved in diverse processes such as oxidative metab-
olism, signal transduction, transport and trafficking. 
Our data suggest complex mechanisms of the 
inhibition of TNF and TNFRI release from the cells 
that may result from the NO RNS-mediated impair-
ment of several distinct processes. PMA-induced 
shedding was more affected than the basal process, 
which may suggest that exogenous NO inhibited 
ADAM17 activity or its activation. Since the mech-
anism of PMA-mediated stimulation of ADAM17 
activity is still unclear, it was not possible to inves-
tigate specific influence of NO on the molecules in-
volved in this process. However, we also observed 
moderate inhibition of ADAM10-induced TNF shed-
ding from the cells deprived of active ADAM17 and 
inhibition of MMPs activity in MBE-SV cells treated 
with SNAP. This finding together with the observa-
tion that the effect of a 24-h incubation of the cells 
with SNAP was stronger than that of a 6-h incuba-
tion suggests the existence of additional, more gen-
eral mechanisms. They do not include an impaired 
cell viability since it was not affected by SNAP or 
PAPA-NO. The slight decrease in the reduction of 
formazan salt by MBE-SV exposed to SNAP for 24 h 
probably resulted from the inhibition of oxidative 
metabolism. The impact of nitric oxide on the mito-
chondrial oxidative chain in MBE cells was already 
suggested by the results of our previous work in 
which we found strong NO-mediated stimulation of 
the expression of a glycolytic enzyme, GAPDH, that 
may compensate for diminished energy supply by 
oxidative metabolism (Bereta & Bereta, 1995). 
A decreased protein synthesis might be par-
tially responsible for the diminished level of TNF 
released from ADAM17–/–TNF+ cells exposed to NO 
donors. However, the small decrease in protein syn-
thesis in MBE-SV and especially in P388/D1 cells 
suggested that this process may only have a minor 
contribution to the limited shedding of TNFR1 or 
TNF in these cells after their incubation with NO 
donors. 
It is also possible that NO may specifically af-
fect the expression of TNF and TNFR1, leading to a 
limited accessibility of the substrates to secretases. 
Indeed, exogenous NO was shown to inhibit cy-
tokine synthesis in alveolar macrophages, but those 
authors used high concentration of the donor that 
led to the generation of 200–750 µM nitrite in the 
culture medium. It is possible that the observed ef-
fect resulted from the inhibition of NF-κB binding to 
the TNF promoter. However, it has been shown that 
nitric oxide inhibits NF-κB–DNA interaction only 
at high concentrations (>250 µM), whereas at lower 
ones it promotes NF-κB-mediated activation of tran-
scription (Umansky et al., 1998; von Knethen et al., 
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1999). The transcription of TNF was shown to be 
stimulated in U937 cells by NO through the inhibi-
tion of interaction of Sp1 with its binding site in TNF 
promoter (Zhang et al., 2003). Moreover, nitric oxide, 
through the activation of p38 MAP kinase, stabilizes 
TNF mRNA (Wang et al., 2008). Thus we should ex-
pect an increase rather than a decrease in TNF level 
in our experimental settings. There are only scarce 
data on the regulation of TNFR1 expression, which 
may suggests that this process is not significantly 
regulated. We have shown that in ADAM17–/–TNF+ 
cells the level of TNF on the cell surface was not di-
minished after a 6-h incubation with SNAP, thus it 
can be concluded that the decrease in shedding oc-
curred even though the availability of the substrate 
to the enzyme was not changed. One could specu-
late that the decrease in TNF shedding should result 
in an increased levels of the membrane cytokine. We 
hypothesize that the unchanged surface level of TNF 
is the outcome of a decreased protein synthesis and 
decreased shedding. 
Zhang et al. (2000) suggested that the stimu-
lation of ADAM17 activity by nitric oxide consisted 
in nitrosylation of the crucial cysteine residue in the 
inhibitory prodomain which led to the activation of 
latent ADAM17. They showed that a prodomain-
derived peptide containing so-called cysteine swich 
inhibited recombinant ADAM17 lacking the prodo-
main and thus constitutively active, and that PAPA-
NO reversed this inhibition through S-nitrosylation 
of the cysteine residue in the peptide (Zhang et al., 
2000). 
However, it has been shown recently that 
the ADAM17 prodomain has a crucial role not only 
in the inhibition of ADAM17 activity but also in its 
maturation. It acts as an ADAM17 chaperone and is 
indispensable for its efficient synthesis. The recom-
binant protein lacking the prodomain undergoes in-
tracellular degradation, probably through the reticu-
lum-proteasome pathway (Milla et al., 2006). Thus, it 
seems possible that nitric oxide through S-nitrosyla-
tion of the cysteine residue within the prodomain 
activates ADAM17 at the late steps of its biogenesis 
but inhibits its proper folding and maturation at early 
stages of the process. This hypothesis could explain 
the discrepancy between the effects of NO observed 
by Zhang and coworkers (2000; 2003) and our group. 
The plasma level of nitrite is often used as a 
marker of nitric oxide synthesis in vivo. It has been 
shown that in the plasma of healthy volunteers the 
concentration of nitrite is 0.12 µM (Dejam et al., 2005). 
During septic shock the levels of nitrite/nitrate dra-
matically increase reaching 17.5 ± 2.56 µM when mul-
tiple organ dysfunction (MOD) is not observed and 
39.1 ± 6.67 µM in case of MOD occurrence (Gomez-
Jimenez et al., 1995). It is possible that locally, at the 
inflammation sites, NO production followed by nitrite 
accumulation is more extensive, but in our opinion it 
would not exceed the values that are obtained in cell 
cultures. Therefore, we used in our experiments the 
concentrations of the NO donor that resulted in nitrite 
accumulation levels close to those obtained when the 
synthesis of endogenous NO was induced. However, 
the kinetics of endo- and exogenous NO generation are 
quite different. The kinetics of nitrite accumulation in 
the culture medium (Fig. 9) may only partially reflect 
the kinetics of NO synthesis and, since nitrite is the fi-
nal product of NO oxidation, it gives no information of 
the NO concentration during experiments. In the case 
of endogenous nitric oxide, the compound is produced 
constantly but at a moderate rate and in the case of 
donor-derived NO the same (or even higher) levels of 
nitrite accumulate much more rapidly (for PAPA-NO, 
immediately), which indicates that the levels of active 
NO is temporarily much higher although transient. 
Moreover, cytokines, simultaneously with the induc-
tion of iNOS expression, modulate the expression of a 
whole set of genes that may influence the occurrence 
of RNS and the effect of nitric oxide generated. This 
may explain the differences in the effect of exogenous 
versus endogenous NO in our experiments. 
In conclusion, we have shown that endog-
enous nitric oxide produced by activated MBE cells 
and P388/D1 cells has no effect on ADAM17 mRNA 
level and on the shedding of TNFR1 and TNF from 
the cell surface. The exposure of cells to SNAP-de-
rived NO caused a decrease in the levels of TNFR1 
and TNF released to the culture medium. The eluci-
dation of the mechanism responsible for this effect 
requires further studies. 
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Figure 9. Kinetics of nitrite accumulation following syn-
thesis of endogenous NO or its release from donors.
Nitrite concentration was measured (A) in medium of 
MBE-SV cells subjected to the cytokines or (B) in medium 
supplemented with NO donors: SNAP (black squares), 
PAPA-NO (white squares). Arrows indicate the moment 
of the addition of the cytokines or NO donors to medium.
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